Hard Lessons: War Stories From The Corporate Innovation Frontlines cover art

Hard Lessons: War Stories From The Corporate Innovation Frontlines

Hard Lessons: War Stories From The Corporate Innovation Frontlines

By: Hard Lessons: War Stories From The Corporate Innovation Frontlines
Listen for free

Corporate innovation sounds exciting until it gets real. Hard Lessons: War Stories from the Corporate Innovation Frontlines is a deep dive into the moments when enterprise innovation pushed limits, broke norms, and forced hard decisions. We talk with innovation leaders inside the world’s largest companies about the deals, bets, pilots, partnerships, and restructurings that shaped outcomes they couldn’t reach any other way. Each episode unpacks one defining moment. What triggered it. What was at risk. Who had to say yes. Who advocated against it. How it played out. And the hard-earned lessons that only come from doing the work, not talking about it. Economics Management Management & Leadership
Episodes
  • Meet the Team: Nagisa Sakurai
    May 18 2026
    We’re pleased to welcome Nagisa Sakurai, who is joining as a Director and as Silicon Foundry’s first Asia-based team member. With a background spanning life sciences, regenerative medicine, corporate venture capital, and corporate innovation, Nagisa brings a multidisciplinary perspective to emerging technologies and global innovation ecosystems. Her experience includes roles across research institutions and industry organizations, including City of Hope Cancer Center, Washington University in St. Louis, and Astellas Pharma. At Silicon Foundry, Nagisa will help strengthen collaboration between Japanese and global innovation ecosystems, working with corporates, startups, and investors to navigate emerging technologies and unlock cross-border opportunities. We recently sat down with Nagisa to learn more about her career journey, Japan’s evolving startup ecosystem, and the future of innovation across Asia and beyond. Press play to listen to this conversation https://sifoundry.com/wp-content/uploads/2026/05/ElevenLabs_MTT_Nagisa_Sakurai.mp3 To start from the very beginning, what would you say first sparked your interest in innovation, venture, or working at the intersection of technology and business? What first got me interested in innovation and the intersection of technology and business was realizing that even great technologies do not automatically create impact unless someone can connect the science and business. During my time working in life sciences, a pivotal moment was when I was evaluating a delivery technology related to cell therapy. Since I had spent almost ten years in that area, I immediately felt the technology had strong potential to become important in the future of cell therapy. However, people on the business side could not clearly see how the technology would create business value. That experience surprised me because we were looking at the same technology inside the same company, but seeing completely different things. Throughout my career, I’ve found that there is a limited number of people who can work between the intersection of science and business, especially when I worked in CVC and corporate innovation. Venture ecosystems often amplify certain technology trends, and startups move very quickly toward those trends, but not corporates. They also have to think about existing businesses, internal priorities, timing, and organizational structure. So I recognized that if we want innovation ecosystems to work well, we need people who can understand and translate between those different worlds. That is still the part of innovation I find the most interesting today. As Silicon Foundry’s first Asia-based team member, what excites you most about this role, and what opportunities do you hope to unlock? I’m excited to help connect Japanese and Asian companies more closely with the global innovation ecosystem, and to bring more visibility to the strengths and perspectives coming from this region. Japanese companies have incredibly strong technical capabilities and deep industry expertise, but there is still a lot of opportunity to strengthen collaboration with global startups and emerging technology ecosystems. At the same time, many startups outside Japan do not fully understand the Japanese market, how Japanese companies make decisions, or what kinds of problems enterprises are actually trying to solve. Because I have worked across life sciences and corporate innovation, I’ve seen how different players operate with very different timelines, incentives, and expectations. Your background spans life sciences as well as venture and corporate innovation. How does that shape the way you evaluate new technologies or opportunities? Does that experience give you a different lens when assessing what will scale or create real impact? My background helps me evaluate both technologies from a technical perspective and how innovation gets adopted and scaled in the real world. Through my experience in life sciences, I saw how long and complex the path can be from breakthrough research to real societal impact. Through my experience in venture ecosystems, I recognized how certain technology trends can attract attention and capital very quickly. But corporates do not always move on the same timeline due to their broad priorities. So when I evaluate new technologies or opportunities, I tend to look not only at whether the technology itself is impressive, but also who will adopt it, whether organizations are ready for it, whether the market timing is right, and how it’ll fit into existing industry structures. Ultimately, I believe technologies scale when these various factors come together at the same time. From your perspective, where do you think Japan is making the most progress in expanding its tech ecosystem, and where is there still room for improvement? The ecosystem has changed significantly over the past five to ten years, but the progress really depends on the ...
    Show More Show Less
    Less than 1 minute
  • The Corporate Venture Trap: Why Chasing VC Returns Is The Wrong Race
    May 18 2026
    Press play to listen to this article https://sifoundry.com/wp-content/uploads/2026/04/ElevenLabs_The_Corporate_Venture_Trap_Why_Chasing_VC_Returns_Is_the_Wrong_Race.mp3 The AI wave is creating the biggest corporate innovation opportunity in a generation. Most CVC programs are too busy copying the VC playbook to seize it. Every few years, corporate venture capital goes through the same cycle: capital floods in, programs launch with ambitious mandates, and most quietly disappear within a few years. It isn’t because they made bad investments, but because they never built a durable reason to exist, one that survives leadership turnover and internal shifts in priority. We are in that cycle again, only this time the stakes are different. In 2025, the global venture market hit $512 billion in deal value, its second-highest year on record. AI accounted for more than half of that total. In the U.S., AI captured nearly two-thirds of all VC deal value, which is up from just 10% a decade ago. Moving away from the sidelines, corporations are right at the center of the boom, with CVC-backed deal activity surging past previous highs. On paper, that looks like maturity. However, in practice, it is the earliest sign of a deepening identity crisis. The Trap Hidden in the Boom The pressure on corporate venture teams right now is not subtle. AI rounds that once took months to close are now closing in just days, with multi-billion dollar financings becoming routine. In that environment, the instinct inside every CVC team is the same: move faster, act more like an independent VC, and optimize for the metrics the board recognizes. That instinct is understandable, but it is also strategically dangerous. The programs that collapse fastest are almost always the ones that most aggressively tried to compete with financial VCs on their own terms. In benchmarking IRR and chasing hot rounds, they lost the one advantage that set them apart: offering founders something no independent fund could. That advantage is not capital, but access to customers, distribution, and internal capabilities that can accelerate a company’s path to scale. The question that needs to be asked is not whether CVCs need more discipline, but what they should be disciplined about. To answer, Harvard Business Review offers an explanation where the central finding directly challenges the dominant narrative: the best-performing CVCs do not succeed by eliminating the tension between startup speed and corporate processes. They succeed by designing mechanisms to make that tension “productive.” The study describes what it calls a “frontstage/backstage” operating model: a fast, founder-oriented external face for deal-making and relationship-building, paired with a structured internal system for activating strategic value through business units. The programs that fail treat these as one job. The programs that last treat them as two distinct, carefully managed ones. In our advisory work at Silicon Foundry, we see this pattern play out consistently: CVC programs that build lasting relationships with founders as well as lasting credibility with their own business units are the ones that invest in internal architecture as seriously as they do in external deal flow. The Unfair Advantage Corporations Are Abandoning No independent VC can offer a live enterprise customer, internal champions, and direct access to distribution, for the right startup, that can compress years of sales into months. The founders who choose a CVC over a financial VC are making a deliberate trade: a smaller check in exchange for strategic access. But that trade only works when the access is enabling, not constraining. Meanwhile, the circular financing model, where corporations invest in AI companies that become major customers of the parent’s own infrastructure, is drawing both regulatory scrutiny and skepticism from founders. This model, which now defines Big Tech’s biggest AI bets, is raising questions about CVC capital coming with strings that look a lot like handcuffs. The data reflects it. At Series D and beyond, CVC-backed companies carry median pre-money valuations of approximately $1.5 billion, roughly three times the median for non-CVC-backed counterparts. That premium is the market pricing of what strategic capital, when deployed correctly, actually delivers. And the value runs in both directions. A peer-reviewed study published in Strategic Change found that CVC investments serve as a key mechanism for accelerating corporate AI adoption, enabling knowledge transfer that compounds over time in ways no internal R&D program alone can replicate. The corporations moving fastest on AI are winning not because they picked the best financial bets, but because they built early relationships with teams shaping the technology. When CVC programs abandon that integration imperative in favor of pure financial benchmarking, the cost compounds quickly. Closure does...
    Show More Show Less
    Less than 1 minute
  • Meet Our Venture Partners: Yuki Shirato
    May 11 2026
    We’re pleased to welcome our newest Venture Partner, Yuki Shirato, Managing Director of Techstars Japan. A seasoned investor, serial entrepreneur, and attorney with more than 25 years of experience across global markets, Yuki has backed over 50 startups as an angel investor and founded Yakumi, an international angel network connecting investors across Japan, the US, Europe, Asia, and the Middle East. He also serves as Senior Advisor at Pangaea Ventures. At Silicon Foundry, Yuki works alongside corporate leaders and venture investors to strengthen cross-border innovation strategies, unlock global startup ecosystems, and translate emerging technologies into durable business growth. We recently sat down with Yuki to learn more about his past experiences and current work today. Press play to listen to this conversation https://sifoundry.com/wp-content/uploads/2026/05/ElevenLabs_Meet_the_Team_Yuki_Shirato.mp3 Across your work in law, startups, and investing, you’ve operated at the intersection of strategy and execution. What has been the consistent thread in how you approach that work? The throughline, for me, is the work of translating complexity into something executable. Whether I was navigating the legal intricacies of cross-border M&As, scaling an early-stage startup, or sitting on the investor side of the table, my focus has always been on translating high-level vision into operational structures that actually work in practice. From the outside, my path may look eclectic and even a bit random: I started my career as a researcher and lobbyist, then moved into management consultancy, then corporate law, and finally became a founder and an investor. However, each move was an intentional step closer to the point where vision meets execution. The roles I’ve taken were less a function of linear progression than a deliberate movement toward where I believe the future is being built: at the seams across disciplines and geographies. What ties it all together is a conviction that the most interesting problems live in those seams, and that someone needs to be fluent enough in each language to hold them together. How has your perspective as a serial entrepreneur shaped the way you evaluate founders? Being a founder myself has taught me that a pitch is just a hypothesis at a particular moment in time. The deck you write in January can mean something completely different by February. This is not because the founder changed, but because the world does. Imagine pitching a portable device the week before the Walkman or iPhone launched, or an AI startup the day before ChatGPT shipped. Overnight, some ideas become obsolete, and others suddenly have a completely new meaning. Founders don’t get to choose when those moments arrive; they only get to choose how they respond. That’s why what I’ve learned to look for is the founder’s underlying operating system. When I evaluate early-stage founders, I prioritize resiliency and persistence without losing drive or momentum. Resilience without momentum becomes stoicism; momentum without resilience burns out. The founders who compound are the ones who can absorb hard feedback, update quickly, and still walk into the next meeting with conviction. Having lived through many of my own pivots and near-misses, I also have a high tolerance for incompleteness and imperfection. I care less about the story’s polish and more about how the founder thinks and demonstrates the vision. In your opinion, what makes an accelerator program genuinely catalytic versus simply supportive? In my mind, being supportive means providing a network and resources, which is, of course, incredibly foundational. A catalyst instead provides velocity, momentum, and compresses years of learning and struggling into only months. The difference usually comes down to two variables: the density and quality of the network the founder is plugged into, and the pressure the program is willing to apply. Programs that simply “support” tend to be comfortable; catalytic programs are productively uncomfortable. At Techstars Tokyo, my method is more Socratic than prescriptive. I try to help founders realize for themselves what needs to be done, rather than handing them a playbook. When a founder concludes their own reasoning, with mentors as a sounding board, that conviction sticks and scales. When you tell them what to do, you’ve created a dependency. Catalytic programs build founders who can think; supportive programs build founders who can follow instructions. What inspired you to found Yakumi, and what gap were you aiming to solve? When I came back to Japan from North America, I saw a massive “trust asymmetry” in early-stage investing. Great deals in Japan couldn’t reach the right global angel investors. At the same time, operators in the US, Europe, and Asia wanted exposure in Japan but had no trusted entry point. The angel ecosystem is fundamentally local and deeply ...
    Show More Show Less
    Less than 1 minute
adbl_web_anon_alc_button_suppression_c
No reviews yet